Terbutaline
Prevention and reversal of bronchospasm in patients 12 years and older
Indications
- Prevention and reversal of bronchospasm in patients 12 years and older
Adult dosing
- bronchospasm: dose: 0.25; unit: mg; route: SC (lateral deltoid); interval: may repeat once in 15-30 min; max 0.5 mg in 4 hours; fixed: true; labelExcerpt: The usual subcutaneous dose of Terbutaline Sulfate Injection, USP is 0.25 mg injected into the lateral deltoid area.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Prolonged tocolysis
- Hypersensitivity to sympathomimetic amines
Clinical pearls
- Not for prolonged tocolysis (beyond 48-72 hours) per boxed warning
- Administer only via subcutaneous route; do not use for intravenous infusion.
- Monitor for cardiovascular effects including pulse rate and blood pressure.
- If additional doses are required, assess for asthma destabilization.
- Use caution in patients with history of cardiovascular disorders.
Source and review
- DailyMed label (terbutaline sulfate), Set ID 9f4b177e-4d7d-4255-afeb-522c7d4594c6, effective 2025-07-16. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties